4SC AG: 4SC publishes Q1 2024 report
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
4SC AG (4SC, FSE Prime Standard: VSC) today published its financial results for the financial year ended 31 December 202…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Eight pre-selected start-ups from medicine and life sciences pitched their business ideas at the 13th BioAngels Pitch Da…
The Board of Management of 4SC AG (4SC, FSE Prime Standard: VSC) announced today that according to its best judgment, th…
As part of this year's BioTech Bootcamp of BioM Biotech Cluster Development GmbH and the life science business incubator…
More than 30 Bavarian biotech companies present medical solutions Munich is a unique ecosystem for globally successf…
Phytopharmaceuticals have been a testament to the natural healing power of the plant world since time immemorial. Their…